The USFDA has approved the Osseo-anchored prostheses for the rehabilitation of amputees (OPRA) implant system for adults who have transfemoral amputations and who already have or are expected to have rehabilitation problems. The OPRA implant system is marketed under the humanitarian device exemption, and the approval currently expands the patient eligibility. The implant is useful in patients who do have a long enough residual limb for attachment of the prosthesis or may have conditions such as recurrent skin infections, pain, scarring, or fluctuating residual limb shape. The device can be installed with two surgical procedures: 1.
A cylinder-shaped fixture is implanted in the central canal of the patient's remaining thigh bone. The secondary surgery is performed six months after the implantation when the tissue has grown to the anchor, and the skin is healed. In this surgery,…
